All Articles

Browse the full archive, newest first.

Briefing: FTSE 100 Live: Stocks plunge as oil soars on Iran attacks, BoE holds rates steady

Strategic angle: Stocks are experiencing a significant drop as oil prices surge following recent attacks in Iran, while the Bank of England maintains its current interest rates.

Editorial Staff Mar 19

Money

Briefing: Clearing the Air: How UNM’s Radiation Exposure Screening and Education Program (RESEP) Helps the Uranium Miners of New Mexico

Strategic angle: UNM's RESEP provides essential support for uranium miners facing radiation exposure.

Editorial Staff Mar 19

Money

Briefing: Stocks to Watch Today: Micron, Rivian, FedEx, Shell

Strategic angle: Key companies to keep an eye on in today's market.

Editorial Staff Mar 19

Politics

Afghanistan accuses Pakistan of killing at least four civilians in Kabul strike

The Taliban government claims airstrikes by Pakistan's military targeted a drug rehabilitation hospital, resulting in civilian casualties.

Editorial Staff Mar 19

Sports

Briefing: Uefa calls leagues to summit over 'microscopic' VAR

Strategic angle: Europe's top leagues are summoned to a meeting with Uefa to discuss how VAR technology is being used.

Editorial Staff Mar 19

Life

Briefing: NASA considering sharp increase in robotic lunar landings

Strategic angle: NASA proposes a significant rise in robotic lunar lander missions, stirring excitement and confusion in the space community.

Editorial Staff Mar 19

Money

Briefing: Gasoline prices hit highest level since March 2022 as oil tops $100

Strategic angle: Gasoline prices have surged, reaching levels not seen since March 2022, driven by rising oil prices.

Editorial Staff Mar 19

Life

Briefing: The best strength training plan might be simpler than you think

Strategic angle: New strength training guidelines emphasize that doing any resistance training is what truly matters.

Editorial Staff Mar 19

Money

Dow Jones Futures Rise, Oil Prices Fall, Nvidia Up On China News; Fed, Micron Earnings Loom

Market updates as Dow futures increase and oil prices decline ahead of key earnings reports.

Editorial Staff Mar 19

Money

Briefing: Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Strategic angle: Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.

Editorial Staff Mar 19